301166 优宁维
已收盘 11-16 15:00:00
资讯
新帖
简况
优宁维(301166)11月12日主力资金净卖出86.14万元
证券之星 · 11-13
优宁维(301166)11月12日主力资金净卖出86.14万元
优宁维:华创证券、财通基金等多家机构于11月11日调研我司
证券之星 · 11-12
优宁维:华创证券、财通基金等多家机构于11月11日调研我司
优宁维(301166)披露参与投资设立基金进展公告,11月05日股价上涨3.55%
证券之星 · 11-05
优宁维(301166)披露参与投资设立基金进展公告,11月05日股价上涨3.55%
股市必读:优宁维新发布《董事会薪酬与考核委员会关于公司2026年限制性股票激励计划授予相关事项的核查意见》
证券之星 · 11-04
股市必读:优宁维新发布《董事会薪酬与考核委员会关于公司2026年限制性股票激励计划授予相关事项的核查意见》
优宁维(301166)2026年三季报简析:营收上升亏损收窄,盈利能力上升
证券之星 · 10-31
优宁维(301166)2026年三季报简析:营收上升亏损收窄,盈利能力上升
图解优宁维三季报:第三季度单季净利润同比增长345.40%
证券之星 · 10-28
图解优宁维三季报:第三季度单季净利润同比增长345.40%
优宁维(301166)9月30日股东户数1.16万户,较上期增加21.96%
证券之星 · 10-27
优宁维(301166)9月30日股东户数1.16万户,较上期增加21.96%
优宁维(301166.SZ)发布前三季度业绩,归母净亏损762.47万元
智通财经 · 10-27
优宁维(301166.SZ)发布前三季度业绩,归母净亏损762.47万元
股市必读:优宁维新发布《2026年限制性股票激励计划实施考核管理办法》
证券之星 · 10-19
股市必读:优宁维新发布《2026年限制性股票激励计划实施考核管理办法》
优宁维(301166)披露2026年限制性股票激励计划草案,10月16日股价下跌2.93%
证券之星 · 10-16
优宁维(301166)披露2026年限制性股票激励计划草案,10月16日股价下跌2.93%
破发股优宁维跌2.93% 2021上市超募13亿国联民生保荐
中金财经 · 10-16
破发股优宁维跌2.93% 2021上市超募13亿国联民生保荐
优宁维(301166)10月12日主力资金净卖出1575.07万元
证券之星 · 10-13
优宁维(301166)10月12日主力资金净卖出1575.07万元
破发股优宁维跌6.48% 2021年上市超募13亿国联民生保荐
中金财经 · 10-12
破发股优宁维跌6.48% 2021年上市超募13亿国联民生保荐
股市必读:优宁维新发布《关于回购公司股份的进展公告》
证券之星 · 10-09
股市必读:优宁维新发布《关于回购公司股份的进展公告》
优宁维(301166)9月30日主力资金净买入1590.04万元
证券之星 · 10-08
优宁维(301166)9月30日主力资金净买入1590.04万元
优宁维(301166)9月23日主力资金净卖出199.93万元
证券之星 · 09-24
优宁维(301166)9月23日主力资金净卖出199.93万元
优宁维:9月16日召开业绩说明会,投资者参与
证券之星 · 09-16
优宁维:9月16日召开业绩说明会,投资者参与
股市必读:优宁维新发布《关于参加2026年上海辖区上市公司集体接待日暨中报业绩说明会活动的公告》
证券之星 · 09-11
股市必读:优宁维新发布《关于参加2026年上海辖区上市公司集体接待日暨中报业绩说明会活动的公告》
优宁维扣非连亏2年半 2021上市超募13亿国联民生保荐
中金财经 · 09-08
优宁维扣非连亏2年半 2021上市超募13亿国联民生保荐
优宁维(301166)披露回购公司股份进展公告,9月1日股价上涨0.44%
证券之星 · 09-01
优宁维(301166)披露回购公司股份进展公告,9月1日股价上涨0.44%
加载更多
公司概况
公司名称:
上海优宁维生物科技股份有限公司
所属行业:
批发业
上市日期:
2021-12-28
主营业务:
上海优宁维生物科技股份有限公司的主营业务是提供以抗体为核心的生命科学试剂及相关仪器、耗材和综合技术服务。公司的主要产品是生命科学试剂及相关仪器、耗材、综合技术服务。
发行价格:
86.06
{"stockData":{"symbol":"301166","market":"SZ","secType":"STK","nameCN":"优宁维","latestPrice":27.94,"timestamp":1794812613000,"preClose":28.68,"halted":0,"volume":1898805,"delay":0,"changeRate":-0.0258,"floatShares":56420500,"shares":86168500,"eps":-0.1799,"marketStatus":"已收盘","change":-0.74,"latestTime":"11-16 15:00:00","open":28.52,"high":28.68,"low":27.5,"amount":53124900,"amplitude":0.0411,"askPrice":27.94,"askSize":89,"bidPrice":27.93,"bidSize":94,"shortable":0,"etf":0,"ttmEps":-0.1799,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794879000000},"marketStatusCode":5,"adr":0,"adjPreClose":28.68,"symbolType":"stock","openAndCloseTimeList":[[1794792600000,1794799800000],[1794805200000,1794812400000]],"highLimit":31.55,"lowLimit":25.81,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":86168468,"isCdr":false,"pbRate":1.27,"roa":"--","roe":"--","epsLYR":-0.26,"committee":0.435583,"marketValue":2408000000,"turnoverRate":0.0337,"status":1,"floatMarketCap":1576000000},"requestUrl":"/m/hq/s/301166","defaultTab":"news","newsList":[{"id":"2683754455","title":"优宁维(301166)11月12日主力资金净卖出86.14万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2683754455","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683754455?lang=zh_cn&edition=full","pubTime":"2026-11-13 09:07","pubTimestamp":1794532038,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年11月12日收盘,优宁维报收于30.04元,上涨1.56%,换手率4.93%,成交量2.78万手,成交额8446.84万元。近5日资金流向一览见下表:优宁维融资融券信息显示,融资方面,当日融资买入761.51万元,融资偿还656.12万元,融资净买入105.39万元。优宁维主营业务:公司面向高等院校、科研院所、医院和生物医药企业等,提供以抗体为核心的生命科学试剂及相关仪器、耗材和综合技术服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111300010014.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301166"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682586774","title":"优宁维:华创证券、财通基金等多家机构于11月11日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2682586774","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682586774?lang=zh_cn&edition=full","pubTime":"2026-11-12 01:04","pubTimestamp":1794416667,"startTime":"0","endTime":"0","summary":"证券之星消息,2026年11月11日优宁维发布公告称华创证券、财通基金于2026年11月11日调研我司。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111200001580.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166","161027","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681074107","title":"优宁维(301166)披露参与投资设立基金进展公告,11月05日股价上涨3.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2681074107","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681074107?lang=zh_cn&edition=full","pubTime":"2026-11-05 22:42","pubTimestamp":1793889738,"startTime":"0","endTime":"0","summary":"截至2026年11月5日收盘,优宁维报收于30.04元,较前一交易日上涨3.55%,最新总市值为25.89亿元。该股当日开盘29.0元,最高30.36元,最低28.72元,成交额达6526.58万元,换手率为3.89%。公司于2026年11月5日披露《关于参与投资设立基金的进展公告》。公告显示,上海优宁维生物科技股份有限公司于2026年10月26日与上海长江国弘投资管理有限公司及其他有限合伙人签署合伙协议,共同出资设立上海国弘医创智合创业投资合伙企业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110500043308.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680771000","title":"股市必读:优宁维新发布《董事会薪酬与考核委员会关于公司2026年限制性股票激励计划授予相关事项的核查意见》","url":"https://stock-news.laohu8.com/highlight/detail?id=2680771000","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680771000?lang=zh_cn&edition=full","pubTime":"2026-11-04 04:03","pubTimestamp":1793736205,"startTime":"0","endTime":"0","summary":"上海市锦天城律师事务所关于上海优宁维生物科技股份有限公司2026年限制性股票激励计划授予事项的法律意见书上海市锦天城律师事务所认为本次限制性股票激励计划的授予事项已履行必要程序,授予条件已成就,授予日、激励对象、授予数量及价格符合相关规定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400006229.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679524298","title":"优宁维(301166)2026年三季报简析:营收上升亏损收窄,盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2679524298","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679524298?lang=zh_cn&edition=full","pubTime":"2026-10-31 03:12","pubTimestamp":1793387548,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期优宁维发布2026年三季报。截至本报告期末,公司营业总收入9.16亿元,同比上升17.97%,归母净利润-762.47万元,同比上升49.44%。按单季度数据看,第三季度营业总收入3.47亿元,同比上升27.94%,第三季度归母净利润417.1万元,同比上升345.4%。本报告期优宁维盈利能力上升,毛利率同比增幅10.66%,净利率同比增幅57.14%。截止目前,公司首发前限售股份均已完成解禁流通。本文数据来源于优宁维2026年三季报,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100004774.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678102972","title":"图解优宁维三季报:第三季度单季净利润同比增长345.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678102972","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678102972?lang=zh_cn&edition=full","pubTime":"2026-10-28 01:32","pubTimestamp":1793122333,"startTime":"0","endTime":"0","summary":"证券之星消息,优宁维2026年三季报显示,前三季度公司主营收入9.16亿元,同比上升17.97%;归母净利润-762.47万元,同比上升49.44%;扣非净利润-1738.83万元,同比上升42.56%;其中2026年第三季度,公司单季度主营收入3.47亿元,同比上升27.94%;单季度归母净利润417.1万元,同比上升345.4%;单季度扣非净利润13.09万元,同比上升101.36%;负债率15.06%,投资收益499.9万元,财务费用-255.57万元,毛利率20.59%。财报数据概要请见下图:本文数据来源于优宁维2026年三季报,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800002652.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678176605","title":"优宁维(301166)9月30日股东户数1.16万户,较上期增加21.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678176605","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678176605?lang=zh_cn&edition=full","pubTime":"2026-10-27 18:56","pubTimestamp":1793098592,"startTime":"0","endTime":"0","summary":"证券之星消息,近日优宁维披露,截至2026年9月30日公司股东户数为1.16万户,较6月30日增加2082.0户,增幅为21.96%。在生物制品行业个股中,优宁维股东户数低于行业平均水平,截至9月30日,生物制品行业平均股东户数为3.67万户。从股价来看,2026年6月30日至2026年9月30日,优宁维区间涨幅为37.07%,在此期间股东户数增加2082.0户,增幅为21.96%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700035709.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678671120","title":"优宁维(301166.SZ)发布前三季度业绩,归母净亏损762.47万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2678671120","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678671120?lang=zh_cn&edition=full","pubTime":"2026-10-27 18:00","pubTimestamp":1793095210,"startTime":"0","endTime":"0","summary":"智通财经APP讯,优宁维(301166.SZ)发布2026年三季度报告,前三季度,公司实现营业收入9.16亿元,同比增长17.97%。归属于上市公司股东净亏损762.47万元。归属于上市公司股东的扣除非经常性损益净亏损1738.83万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1513402.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301166","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676573462","title":"股市必读:优宁维新发布《2026年限制性股票激励计划实施考核管理办法》","url":"https://stock-news.laohu8.com/highlight/detail?id=2676573462","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676573462?lang=zh_cn&edition=full","pubTime":"2026-10-19 03:44","pubTimestamp":1792352651,"startTime":"0","endTime":"0","summary":"公司公告汇总2026年限制性股票激励计划实施考核管理办法上海优宁维生物科技股份有限公司制定2026年限制性股票激励计划实施考核管理办法,考核范围包括董事、高级管理人员及核心管理人员。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900001138.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675518788","title":"优宁维(301166)披露2026年限制性股票激励计划草案,10月16日股价下跌2.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675518788","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675518788?lang=zh_cn&edition=full","pubTime":"2026-10-16 22:50","pubTimestamp":1792162226,"startTime":"0","endTime":"0","summary":"截至2026年10月16日收盘,优宁维报收于31.1元,较前一交易日下跌2.93%,最新总市值为26.8亿元。公告显示,公司定于2026年11月3日召开2026年第三次临时股东会,股权登记日为2026年10月27日。其中,《2026年限制性股票激励计划(草案)》及其摘要、实施考核管理办法、授权董事会办理相关事宜的议案为特别决议事项,需经出席会议股东所持有效表决权的2/3以上通过,且关联股东应回避表决。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600040824.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675756231","title":"破发股优宁维跌2.93% 2021上市超募13亿国联民生保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2675756231","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675756231?lang=zh_cn&edition=full","pubTime":"2026-10-16 16:13","pubTimestamp":1792138385,"startTime":"0","endTime":"0","summary":"中国经济网北京10月16日讯 优宁维 今日收报31.10元,跌幅2.93%。该股目前处于破发状态。 优宁维于2021年12月28日在深交所创业板上市,公开发行股票2166.67万股,发行价格为86.06元/股,保荐机构为国联民生,保荐代表人为梁军、卞进。 优宁维首次公开发行股票募集资金总额为18.65亿元,扣除发行费用后,募集资金净额为15.96亿元。 优宁维首次公开发行股票发行费用合计2.69亿元,其中,承销及保荐费用2.48亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20261016/32399446.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["IPOS","BK1564","301166","BK0276","601456","BK0250","BK1147","01456"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675389272","title":"优宁维(301166)10月12日主力资金净卖出1575.07万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675389272","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675389272?lang=zh_cn&edition=full","pubTime":"2026-10-13 09:14","pubTimestamp":1791854075,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年10月12日收盘,优宁维报收于34.06元,下跌6.48%,换手率10.13%,成交量5.72万手,成交额1.98亿元。近5日资金流向一览见下表:优宁维融资融券信息显示,融资方面,当日融资买入1153.21万元,融资偿还1951.05万元,融资净偿还797.84万元。优宁维主营业务:公司面向高等院校、科研院所、医院和生物医药企业等,提供以抗体为核心的生命科学试剂及相关仪器、耗材和综合技术服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300008434.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301166"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674820124","title":"破发股优宁维跌6.48% 2021年上市超募13亿国联民生保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2674820124","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674820124?lang=zh_cn&edition=full","pubTime":"2026-10-12 16:17","pubTimestamp":1791793023,"startTime":"0","endTime":"0","summary":"中国经济网北京10月12日讯 优宁维 今日收报34.06元,跌幅6.48%。 优宁维于2021年12月28日在深交所创业板上市,公开发行股票2166.67万股,发行价格为86.06元/股,保荐机构为国联民生,保荐代表人为梁军、卞进。 优宁维首次公开发行股票募集资金总额为18.65亿元,扣除发行费用后,募集资金净额为15.96亿元。优宁维最终募集资金净额比原计划多13.12亿元。 优宁维首次公开发行股票发行费用合计2.69亿元,其中,承销及保荐费用2.48亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20261012/32393634.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0250","301166","601456","BK0276","BK1147","01456","IPOS","BK1564"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674057004","title":"股市必读:优宁维新发布《关于回购公司股份的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674057004","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674057004?lang=zh_cn&edition=full","pubTime":"2026-10-09 02:19","pubTimestamp":1791483549,"startTime":"0","endTime":"0","summary":"截至2026年10月8日收盘,优宁维报收于35.11元,下跌0.68%,换手率9.17%,成交量5.17万手,成交额1.82亿元。当日关注点交易信息汇总:10月8日主力资金净流入382.12万元,占总成交额2.1%。公司公告汇总:截至2026年9月30日,优宁维已累计回购291,100股,占总股本0.34%,支付总金额7,496,566元,回购价格区间为24.16元/股至28.00元/股,回购价格上限已调整为不超过44.41元/股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900002199.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301166"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673049233","title":"优宁维(301166)9月30日主力资金净买入1590.04万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2673049233","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673049233?lang=zh_cn&edition=full","pubTime":"2026-10-08 09:02","pubTimestamp":1791421348,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年9月30日收盘,优宁维报收于35.35元,上涨7.25%,换手率8.24%,成交量4.65万手,成交额1.62亿元。近5日资金流向一览见下表:优宁维融资融券信息显示,融资方面,当日融资买入1783.67万元,融资偿还1211.76万元,融资净买入571.91万元。优宁维主营业务:公司面向高等院校、科研院所、医院和生物医药企业等,提供以抗体为核心的生命科学试剂及相关仪器、耗材和综合技术服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800002861.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669943012","title":"优宁维(301166)9月23日主力资金净卖出199.93万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2669943012","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669943012?lang=zh_cn&edition=full","pubTime":"2026-09-24 09:09","pubTimestamp":1790212184,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2026年9月23日收盘,优宁维报收于33.03元,上涨2.67%,换手率5.26%,成交量2.97万手,成交额9709.87万元。近5日资金流向一览见下表:优宁维融资融券信息显示,融资方面,当日融资买入751.0万元,融资偿还804.78万元,融资净偿还53.78万元。优宁维主营业务:公司面向高等院校、科研院所、医院和生物医药企业等,提供以抗体为核心的生命科学试剂及相关仪器、耗材和综合技术服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400009005.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301166"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667857869","title":"优宁维:9月16日召开业绩说明会,投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2667857869","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667857869?lang=zh_cn&edition=full","pubTime":"2026-09-16 21:04","pubTimestamp":1789563890,"startTime":"0","endTime":"0","summary":"证券之星消息,2026年9月16日优宁维发布公告称公司于2026年9月16日召开业绩说明会。相关进展投资者可关注公司披露的相关临时公告和定期报告。以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091600035785.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301166","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666590163","title":"股市必读:优宁维新发布《关于参加2026年上海辖区上市公司集体接待日暨中报业绩说明会活动的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2666590163","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666590163?lang=zh_cn&edition=full","pubTime":"2026-09-11 02:08","pubTimestamp":1789063695,"startTime":"0","endTime":"0","summary":"公司公告汇总:优宁维将于2026年9月16日15:00–17:00通过“全景路演”平台举行中报业绩说明会,董事长兼总经理冷兆武等高管将在线交流。公司公告汇总关于参加2026年上海辖区上市公司集体接待日暨中报业绩说明会活动的公告上海优宁维生物科技股份有限公司将参加由中国证券监督管理委员会上海监管局指导、上海上市公司协会及深圳市全景网络有限公司联合举办的“2026年上海辖区上市公司集体接待日暨中报业绩说明会活动”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100002573.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301166"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665932885","title":"优宁维扣非连亏2年半 2021上市超募13亿国联民生保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2665932885","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665932885?lang=zh_cn&edition=full","pubTime":"2026-09-08 15:05","pubTimestamp":1788851103,"startTime":"0","endTime":"0","summary":"中国经济网北京9月8日讯 优宁维 近期发布2026年半年度报告。 优宁维2024年至2025年归属于上市公司股东的净利润分别为1014.90万元、-2294.87万元;归属于上市公司股东的扣除非经常性损益的净利润分别为-1511.00万元、-4321.38万元。 优宁维首次公开发行股票发行费用合计2.69亿元,其中,承销及保荐费用2.48亿元。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/08/20260908921332.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/08/20260908921332.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260908/32363254.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1564","BK0276","601456","301166","BK0250","IPOS","01456","BK1147"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664485035","title":"优宁维(301166)披露回购公司股份进展公告,9月1日股价上涨0.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664485035","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664485035?lang=zh_cn&edition=full","pubTime":"2026-09-01 23:08","pubTimestamp":1788275297,"startTime":"0","endTime":"0","summary":"截至2026年9月1日收盘,优宁维报收于29.4元,较前一交易日上涨0.44%,最新总市值为25.33亿元。该股当日开盘29.27元,最高29.66元,最低29.06元,成交额达5171.81万元,换手率为3.12%。优宁维于近日披露《关于回购公司股份的进展公告》。回购价格上限已由45元/股调整为44.41元/股。本次回购符合相关规定,公司后续将在回购期限内继续实施回购计划并履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100043595.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301166"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1794816516548,"stockEarnings":[{"period":"1week","weight":-0.0134},{"period":"1month","weight":-0.1333},{"period":"3month","weight":-0.0584},{"period":"6month","weight":-0.0552},{"period":"1year","weight":-0.1255},{"period":"ytd","weight":-0.0129}],"compareEarnings":[{"period":"1week","weight":-0.0041},{"period":"1month","weight":-0.0353},{"period":"3month","weight":-0.0746},{"period":"6month","weight":-0.1212},{"period":"1year","weight":-0.0981},{"period":"ytd","weight":-0.0843}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海优宁维生物科技股份有限公司","boardCode":"AI0051","boardName":"批发业","stockholders":"11564人(较上一季度增加21.96%)","perCapita":"4878股","listingDate":"2021-12-28","address":"上海市杨浦区控江路1690号1505室","registeredCapital":"8616万元","survey":" 上海优宁维生物科技股份有限公司的主营业务是提供以抗体为核心的生命科学试剂及相关仪器、耗材和综合技术服务。公司的主要产品是生命科学试剂及相关仪器、耗材、综合技术服务。","listedPrice":86.06},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.54.0","shortVersion":"4.54.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"优宁维(301166)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供优宁维(301166)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"优宁维,301166,优宁维股票,优宁维股票老虎,优宁维股票老虎国际,优宁维行情,优宁维股票行情,优宁维股价,优宁维股市,优宁维股票价格,优宁维股票交易,优宁维股票购买,优宁维股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"优宁维(301166)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供优宁维(301166)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}